Eastern Biotech & Life Sciences, Dubai based company established in Dubiotech Park introducing new Cardiovascular Assessment on the cutting edge of molecular medicine in Middle East Region.
Eastern Biotech & Life Sciences, Dubai based company established in Dubiotech Park introducing new Cardiovascular Assessment on the cutting edge of molecular medicine in Middle East Region. Based on the latest advancements in cardiovascular research, this groundbreaking assessment measures the most important CVD markers available, including crucial new independent factors, a diverse array of lipoproteins, and two computed ratios. All of these advanced markers play a critical role in assessing the biochemical environment underlying cardiovascular health. This information allows the clinician to accurately address abnormalities relating to heart and vascular diseases.According to Mr. Pankaj Sohaney-Manager, Middle East using this state-of-the-art assessment, you can now better identify individuals who don't show abnormalities in traditional markers of CVD-those who comprise almost 50 percent of all heart attack victims. A clear, color-coded test report will allow you to quickly interpret results, and design a unique, customized nutrition therapy program that can dramatically improve a patient's quality of life, and possibly even save it.Perhaps the greatest tragedy is that the deleterious consequences of this deadly disease are very often preventable. With advances in medicine, researchers have discovered important early indicators that can significantly change the direction of prophylactic and therapeutic treatment, decreasing the incidence and halting the progression of the disease.Testing is strongly recommended for patients with the following history or medical conditions:· Family history of cardiovascular disease · Personal history of myocardial infarction, peripheral artery disease, or coronary artery disease · Obesity · Diabetes · Hypertension · Thyroid disorders · Stress · Chronic illness ( including chronic fatigue ) · Diets high in saturated and trans fats · Sedentary lifestyle · Use of alcohol,nicotine,drugs ( including certain medications ) · Use of oral contraceptives · Hormonal imbalances ( estradiol, cortisol, insulin, melatonin ) · Post-menopause · Renal disease The Comprehensive Cardiovascular Profile 2.0 incorporates the latest breakthroughs in cardiovascular disease research to provide advanced, early warning of CVD risk. This thorough evaluation features an advanced lipid profile with fractionation, independent risk markers ( including homocysteine and hs-C-reactive protein ), relative risk indices, and Metabolic Syndrome alerts. All of these advanced markers play a critical role in the biochemical environment underlying cardiovascular health. The insight they provide allows the clinician to accurately address abnormalities relating to heart and vascular diseases.A clear, color-coded test report allows the clinician to quickly interpret results and design a novel, custom-tailored prevention program that can dramatically improve a patient's quality of life, and possibly even save it. The kit is developed by Genova Diagnostics and in Middle East it is available and promoted through Eastern Biotech Life Sciences FZ-LLC, anyone can get it by courier after calling +97143692061 or sending mail to info@easternbiotech.comEastern Biotech & Life Sciences based at DuBiotech, Dubai, is the first company in the Middle East to offer comprehensive genetic testing services. We have carefully examined the biotechnological horizon to identify the genetic tests most relevant to this region and offer them directly to the people of the Middle East.If you have questions regarding information in this press release contact the company listed below. I-Newswire.com is a press release service and not the author of this press release. The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies / PR Agencies submit their press releases once per week/month or quarter, make sure check the official company website for accurate release dates as our site displays the I-Newswire.com distribution date only. We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.
Thursday, August 30, 2007
Friday, August 24, 2007
Tuesday, August 21, 2007
HOME TESTING KITS FOR PREDICTIVE GENETIC TEST
United Arab Emirates. - Its vision is to promote the health of the people of the United Arab Emirates and the region through the introduction of biotechnological products and systems, and through research into the diseases relevant to this region, especially genetic disorders. Eastern Biotech is providing these home testing kits through Genova Diagnostics. The Human Genome Project has made one of the biggest contributions to the medical diagnosis by revealing an individual’s potential susceptibility to specific diseases and analyzing one’s risk to various diseased conditions. The prediction of various diseases is a quite common thing practiced among the people in Europe and USA. Eastern Biotech & Life Sciences introduces, for the first time in the Middle East, the similar highly accurate gene-based “traffic report” called GENOVATIONS which can clearly pinpoint health risks which previously would have been hidden out-of-sight “over the horizon”. With this new information, you and your physician can chart an alternate route, a smart health “detour”, so you can avoid the health conditions you could to encounter otherwise. None of us are perfect and neither are our genes. Within your genetic makeup, there are slight “variations” called Single Nucleotide Polymorphisms (commonly called SNP s, pronounced “snips”). Although they don’t cause disease, SNPs are associated with almost every human disease. The “expression” of one’s genes into an actual disease isn’t inevitable, as many people think. The genomic variations make a person particularly susceptible to a specific type of disease when exposed to certain, often modifiable factors, such as your environment, diet and lifestyle. It isn’t the “fate” of any of your genes (even your SNPs) to express themselves as a disease. It is a combination of both your genes and modifiable environment which are responsible for various diseases which we encounter during our life time. And that’s where Genovations comes to help us. By taking a simple test, it can inform you and your physician of the specific SNPs you have, making it possible to plan a way “around” your potential risk. Since it takes your genes and their “environment” to trigger most disease, you can easily take your personalized “alternate route” to avoid the risks, and enjoy a healthier journey in life.When conditions “run in families” they often have a genetic component. This test can show what specific genomic factors might pose a potential problem for You. If you learn you have a modifiable genetic variation, Your Family Members can also be tested to see whether they have it. The sooner it’s known, the sooner you and/or they can begin changing course toward a healthier future.In primary care practice, Genovations™ will significantly improve healthcare interventions for patients in three major areas:Predictive AssessmentGenetic testing provides the foundation for more effective, timely, and customized preventive strategies based on each patient’s unique genetic predisposition. This provides all health-conscious patients with the expanded insight they need to adopt more effective and focused risk-minimizing strategies to improve and protect their health.Familial AssociationsPatients with family history of a certain disease can learn if they have inherited a genetic predisposition for this condition and, if so, what they can specifically do to "break the pattern" and better prevent it.Challenging PatientsGenetic testing provides insight into individual genetic variations that can help explain why certain patients may not be responding to clinical interventions that normally produce favorable outcomesTo see if you should be tested for any or all of the health problems, simply call us at +971 4 3692061 or email us at info@easternbiotech.com or visit our website www.easternbiotech.com to know more about the tests.
Eastern Biotech launches Rapid Diagnostic kits for Bird flu, Malaria, Dengue fever in India & Africa
Dubai(UAE): Eastern Biotech & Life Sciences, UAE, a company established in Dubiotech Park, Dubai, announced the launch of In Vitro diagnostic kits for avian influenza, malaria and dengue fever and many other rapid tests for self testing in India & Africa.
Currently the Company is working into 6 different countries and has had requests for information from another 12 countries. Indian is biggest market for these kits in the world. With the start of the mosquito season in many tropical countries it appears that Dengue Fever is becoming prevalent throughout the Middle East, Malaysia, and Southeast Asia. Dengue Fever comes in 4 forms. In the mildest form it can incapacitate an individual for up to 6 months. In the worst form the individual dies within days through massive hemorrhaging. The only treatment is fluid replacement therapy which must be started immediately. Standard laboratories take a minimum of three (3) days to as long as twenty-one (21) days to complete the testing. Very few laboratories are even capable of doing the testing for Dengue Fever.
The Eastern Biotech rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Dengue Fever, Syphilis, Malaria, and Cancer. The kits can be used Worldwide except UAE.
The last few months have been really good for Eastern Biotech. We have received good order from an UK-based company for making pregnancy kits. "I have received a sizable order from South Africa & India as well. Some more orders we will be getting from South Africa every other month now. The orders are now picking up," shared Pankaj Sohaney, Manager Marketing and business development.
"Right now, most diagnosis of dengue is done as an academic exercise - after the event in India. Our test will enable rapid diagnosis of dengue to monitored and diagnosed." Said Junaid Faruq, Director of Marketing.
For more details please write us info@easternbiotech.com
Currently the Company is working into 6 different countries and has had requests for information from another 12 countries. Indian is biggest market for these kits in the world. With the start of the mosquito season in many tropical countries it appears that Dengue Fever is becoming prevalent throughout the Middle East, Malaysia, and Southeast Asia. Dengue Fever comes in 4 forms. In the mildest form it can incapacitate an individual for up to 6 months. In the worst form the individual dies within days through massive hemorrhaging. The only treatment is fluid replacement therapy which must be started immediately. Standard laboratories take a minimum of three (3) days to as long as twenty-one (21) days to complete the testing. Very few laboratories are even capable of doing the testing for Dengue Fever.
The Eastern Biotech rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Dengue Fever, Syphilis, Malaria, and Cancer. The kits can be used Worldwide except UAE.
The last few months have been really good for Eastern Biotech. We have received good order from an UK-based company for making pregnancy kits. "I have received a sizable order from South Africa & India as well. Some more orders we will be getting from South Africa every other month now. The orders are now picking up," shared Pankaj Sohaney, Manager Marketing and business development.
"Right now, most diagnosis of dengue is done as an academic exercise - after the event in India. Our test will enable rapid diagnosis of dengue to monitored and diagnosed." Said Junaid Faruq, Director of Marketing.
For more details please write us info@easternbiotech.com
Subscribe to:
Posts (Atom)
